Literature DB >> 8273839

Candida sepsis in surgical patients.

P J Eubanks1, C de Virgilio, S Klein, F Bongard.   

Abstract

Candidemia in critically ill patients is a significant source of mortality. To identify perioperative risk factors accounting for patient death, we performed a retrospective study of 46 surgical patients with fungemia during the period from 1981 to 1990. Twenty patients survived (43%), and 26 died (57%). Mortality was associated with age older than 46 (p < 0.02, unpaired Student's t-test) and concomitant renal failure, hepatic failure, postoperative shock, or adult respiratory distress syndrome (p < 0.0001, p < 0.0001, and p < 0.05, respectively, chi 2 test). Survival was not influenced by the presence of diabetes, chronic obstructive pulmonary disease, gastrointestinal hemorrhage, pneumonia, alcohol consumption, steroid use, or enteral/parental nutrition. Bacterial speticemia developed in 26 patients (11 lived, 15 died) and typically preceded or was concomitant with the onset of fungal sepsis (88%). Candida albicans was the fungal species most commonly isolated from blood cultures (30 of 46). Its was cultured from other sites in addition to blood in 30 patients. Candidemia carries a higher risk of mortality in older patients and in those with multiple organ dysfunction. Other immunocompromised conditions such as diabetes and steroid use did not increase mortality. These findings suggest that the pathogenicity of Candida sepsis is not solely related to opportunistic superinfections but may reflect failure of other host defense mechanisms. Moreover, the frequent occurrence of bacterial septicemia prior to the development of Candida sepsis further emphasizes the importance of fungal surveillance cultures to detect early fungal colonization in the critically ill.

Entities:  

Mesh:

Year:  1993        PMID: 8273839     DOI: 10.1016/s0002-9610(05)80666-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Experience with invasive Candida infections.

Authors:  H Girishkumar; A M Yousuf; J Chivate; E Geisler
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

2.  Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery.

Authors:  Yan-Shen Shan; Edgar D Sy; Shan-Tair Wang; Jenq-Chang Lee; Pin-Wen Lin
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  Gastrointestinal colonization by Candida albicans mutant strains in antibiotic-treated mice.

Authors:  S M Wiesner; R P Jechorek; R M Garni; C M Bendel; C L Wells
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

4.  Practices in non-neutropenic ICU patients with Candida-positive airway specimens.

Authors:  Elie Azoulay; Yves Cohen; Jean-Ralph Zahar; Maité Garrouste-Orgeas; Christophe Adrie; Pierre Moine; Arnaud de Lassence; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

Review 5.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Clinical aspects of invasive candidiasis in the surgical patient.

Authors:  Gabriele Sganga
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Candidemia in critically ill patients: difference of outcome between medical and surgical patients.

Authors:  Pierre Emmanuel Charles; Jean Marc Doise; Jean Pierre Quenot; Hervé Aube; Frédéric Dalle; Pascal Chavanet; Nadine Milesi; Ludwig Serge Aho; Henri Portier; Bernard Blettery
Journal:  Intensive Care Med       Date:  2003-09-10       Impact factor: 17.440

8.  Pancreatic juice leakage is a risk factor for deep mycosis after pancreatic surgery.

Authors:  Yukihiro Iso; Tokihiko Sawada; Nobumi Tagaya; Masato Kato; Kyu Rokkaku; Mitsugi Shimoda; Junji Kita; Keiichi Kubota
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.